STANDARDISIERTES UND OPTIMIERTES QUANTITATIVES REVERSE-TRANSKRIPTASE ECHTZEIT- POLYMERASEKETTENREAKTIONSVERFAHREN ZUM NACHWEIS VON MINIMALEN RESTERKRANKUNGEN BEI LEUKÄMIE

The application relates to sets of nucleic acid probes and primers and their use in a method for detection of minimal residual disease in leukemic patients, in which at least one PML-RARA fusion gene transcript variant is amplified and detected.

Saved in:
Bibliographic Details
Main Authors GABERT, JEAN, BI, WANLI, VAN DONGEN, JACQUES, BEILLARD, EMMANUEL
Format Patent
LanguageGerman
Published 15.10.2009
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The application relates to sets of nucleic acid probes and primers and their use in a method for detection of minimal residual disease in leukemic patients, in which at least one PML-RARA fusion gene transcript variant is amplified and detected.
Bibliography:Application Number: AT20070007462T